MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, PAVM has $45,419K in assets. $20,431K in debts. $6,460K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
202.35%
Quick Ratio
202.35%
Cash Ratio
176.31%
Debt to Asset Ratio
44.98%
Unit: Thousand (K) dollars
Assets Breakdown
    • Equity method investment - at fa...
    • Cash
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Total pavmed stockholders equity...
    • Senior secured convertible notes...
    • Noncontrolling interests
    • Others

Balance Sheets
2026-03-31
2025-09-30
2025-06-30
Cash
-3,103 4,004
Accounts receivable
-3 3
Cash
6,460 --
Accounts receivable
21 --
Prepaid expenses, deposits, and other current assets
933 1,085 1,481
Total current assets
7,414 4,191 5,488
Fixed assets, net
79 81 100
Operating lease right-of-use assets
1,872 2,131 2,256
Equity method investment - at fair value
35,998 31,615 35,998
Other assets
56 51 51
Total assets
45,419 38,069 43,893
Accounts payable
983 342 387
Accrued expenses and other current liabilities
2,093 2,660 2,777
Operating lease liabilities, current portion
588 557 542
Senior secured convertible notes - at fair value
0 6,900 6,800
Total current liabilities
3,664 10,459 10,506
Senior secured convertible notes - at fair value
14,900 --
Rights liability
345 --
Operating lease liabilities, less current portion
1,522 1,823 1,968
Total liabilities
20,431 12,282 12,474
Preferred stock, 0.001 par value. authorized, 20,000,000 shares series c convertible preferred stock, stated value 1,058 at september 30, 2025, and issued and outstanding of 3,081 shares at september 30, 2025 and no shares issued and outstanding as of december 31, 2024
-3,260 3,260
Preferred stock, value-Series BConvertible Preferred Stock
-3,575 3,487
Preferred stock-Series BPreferred Stock
3,757 --
Preferred stock, value-Series CConvertible Preferred Stock
-20,492 21,083
Preferred stock-Series CPreferred Stock
0 --
Common stock, 0.001 par value. authorized, 25,000,000 shares (note 12) 6,269,384 and 927,934 shares outstanding as of march 31, 2026 and december 31, 2025, respectively
6 23 20
Additional paid-in capital
294,788 265,331 263,515
Accumulated deficit
-259,028 -256,901 -250,575
Total pavmed stockholders equity (deficit)
39,523 32,520 37,530
Noncontrolling interests
-14,535 -9,993 -9,371
Total stockholders equity (deficit)
24,988 22,527 28,159
Total liabilities and stockholders equity
45,419 38,069 43,893
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash$6,460K Prepaid expenses,deposits, and other...$933K Accounts receivable$21K Equity methodinvestment - at fair value$35,998K Total current assets$7,414K Operating leaseright-of-use assets$1,872K Fixed assets, net$79K Other assets$56K Total assets$45,419K Total liabilities andstockholders equity$45,419K Total stockholdersequity (deficit)$24,988K Total liabilities$20,431K Noncontrolling interests-$14,535K Total pavmedstockholders equity...$39,523K Senior securedconvertible notes - at fair...$14,900K Total currentliabilities$3,664K Operating leaseliabilities, less current...$1,522K Rights liability$345K Accumulated deficit-$259,028K Additional paid-in capital$294,788K Accrued expenses andother current...$2,093K Accounts payable$983K Operating leaseliabilities, current portion$588K Preferred stock-SeriesBPreferred Stock$3,757K Common stock, 0.001 parvalue. authorized,...$6K